ResearcherLeiden University Medical CenterNo recent work listed
Rob A.E.M. Tollenaar
Matched on ORCID iD 0000-0002-6831-6082; OpenAlex author ID A5031930566. Sources: OpenAlex.
Their work
- Papers
- 10 (first author 0, last author 4)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 33
2011: 1 paper · 2012: none · 2013: 1 paper · 2014: 1 paper · 2015: 1 paper · 2016: 1 paper · 2017: none · 2018: 1 paper · 2019: none · 2020: 1 paper · 2021: 2 papers · 2022: 1 paper
Papers 10
- Longitudinal changes of serum protein N-Glycan levels for earlier detection of pancreatic cancer in high-risk individuals. Co-author DOI 10.1016/j.pan.2022.03.021↗
- Incidence, timing and risk factors of venous thromboembolic events in patients with pancreatic cancer. Co-author DOI 10.1016/j.thromres.2021.08.002↗
- Clinical Perspective on Proteomic and Glycomic Biomarkers for Diagnosis, Prognosis, and Prediction of Pancreatic Cancer. Last author DOI 10.3390/ijms22052655↗
- Serum N-Glycome analysis reveals pancreatic cancer disease signatures. Last author DOI 10.1002/cam4.3439↗
- High Growth Rate of Pancreatic Ductal Adenocarcinoma in CDKN2A-p16-Leiden Mutation Carriers. Co-author DOI 10.1158/1940-6207.capr-18-0035↗
- Application of a Serum Protein Signature for Pancreatic Cancer to Separate Cases from Controls in a Pancreatic Surveillance Cohort. Co-author DOI 10.1016/j.tranon.2016.03.003↗
- Serum peptide signatures for pancreatic cancer based on mass spectrometry: a comparison to CA19-9 levels and routine imaging techniques. Last author DOI 10.1007/s00432-014-1812-2↗
- Impact of centralization of pancreatic cancer surgery on resection rates and survival. Co-author DOI 10.1002/bjs.9468↗
- Detection of pancreatic cancer using serum protein profiling. Last author DOI 10.1111/hpb.12017↗
- Magnetic resonance imaging surveillance detects early-stage pancreatic cancer in carriers of a p16-Leiden mutation. Co-author DOI 10.1053/j.gastro.2010.11.048↗
Closest collaborators
The 25 strongest of 33 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Bert A. Bonsing · 10 shared papers, 2011–2022 · strength 0.76
- Paper Clinical Perspective on Proteomic and Glycomic Biomarkers for Diagnosis, Prognosis, and Prediction of Pancreatic Cancer. DOI 10.3390/ijms22052655↗
- Paper Incidence, timing and risk factors of venous thromboembolic events in patients with pancreatic cancer. DOI 10.1016/j.thromres.2021.08.002↗
- Paper Longitudinal changes of serum protein N-Glycan levels for earlier detection of pancreatic cancer in high-risk individua… DOI 10.1016/j.pan.2022.03.021↗
- Wilma E. Mesker · 7 shared papers, 2013–2022 · strength 0.63
- Paper Clinical Perspective on Proteomic and Glycomic Biomarkers for Diagnosis, Prognosis, and Prediction of Pancreatic Cancer. DOI 10.3390/ijms22052655↗
- Paper Incidence, timing and risk factors of venous thromboembolic events in patients with pancreatic cancer. DOI 10.1016/j.thromres.2021.08.002↗
- Paper Longitudinal changes of serum protein N-Glycan levels for earlier detection of pancreatic cancer in high-risk individua… DOI 10.1016/j.pan.2022.03.021↗
- Yuri E. M. van der Burgt · 6 shared papers, 2013–2022 · strength 0.50
- Paper Clinical Perspective on Proteomic and Glycomic Biomarkers for Diagnosis, Prognosis, and Prediction of Pancreatic Cancer. DOI 10.3390/ijms22052655↗
- Paper Longitudinal changes of serum protein N-Glycan levels for earlier detection of pancreatic cancer in high-risk individua… DOI 10.1016/j.pan.2022.03.021↗
- Paper Serum N-Glycome analysis reveals pancreatic cancer disease signatures. DOI 10.1002/cam4.3439↗
- Hans F. A. Vasen · 7 shared papers, 2011–2022 · strength 0.49
- Paper Clinical Perspective on Proteomic and Glycomic Biomarkers for Diagnosis, Prognosis, and Prediction of Pancreatic Cancer. DOI 10.3390/ijms22052655↗
- Paper Longitudinal changes of serum protein N-Glycan levels for earlier detection of pancreatic cancer in high-risk individua… DOI 10.1016/j.pan.2022.03.021↗
- Paper High Growth Rate of Pancreatic Ductal Adenocarcinoma in CDKN2A-p16-Leiden Mutation Carriers. DOI 10.1158/1940-6207.capr-18-0035↗
- Randa G. Hanna-Sawires · 4 shared papers, 2020–2022 · strength 0.48
- Paper Clinical Perspective on Proteomic and Glycomic Biomarkers for Diagnosis, Prognosis, and Prediction of Pancreatic Cancer. DOI 10.3390/ijms22052655↗
- Paper Incidence, timing and risk factors of venous thromboembolic events in patients with pancreatic cancer. DOI 10.1016/j.thromres.2021.08.002↗
- Paper Longitudinal changes of serum protein N-Glycan levels for earlier detection of pancreatic cancer in high-risk individua… DOI 10.1016/j.pan.2022.03.021↗
- Manfred Wuhrer · 3 shared papers, 2020–2022 · strength 0.36
- Paper Clinical Perspective on Proteomic and Glycomic Biomarkers for Diagnosis, Prognosis, and Prediction of Pancreatic Cancer. DOI 10.3390/ijms22052655↗
- Paper Longitudinal changes of serum protein N-Glycan levels for earlier detection of pancreatic cancer in high-risk individua… DOI 10.1016/j.pan.2022.03.021↗
- Paper Serum N-Glycome analysis reveals pancreatic cancer disease signatures. DOI 10.1002/cam4.3439↗
- Monique Esther van Leerdam · 2 shared papers, 2021–2022 · strength 0.26
- Paper Clinical Perspective on Proteomic and Glycomic Biomarkers for Diagnosis, Prognosis, and Prediction of Pancreatic Cancer. DOI 10.3390/ijms22052655↗
- Paper Longitudinal changes of serum protein N-Glycan levels for earlier detection of pancreatic cancer in high-risk individua… DOI 10.1016/j.pan.2022.03.021↗
- Gerda C. M. Vreeker · 2 shared papers, 2020–2022 · strength 0.22
- Isaura S. Ibrahim · 2 shared papers, 2018–2022 · strength 0.19
- Jesse V. Groen · 1 shared paper, 2021 · strength 0.12
- J. Sven D. Mieog · 1 shared paper, 2021 · strength 0.12
- Alexander L. Vahrmeijer · 1 shared paper, 2021 · strength 0.12
- Brechtje D.M. Koopmann · 1 shared paper, 2022 · strength 0.12
- Iris J. M. Levink · 1 shared paper, 2022 · strength 0.12
- Kasper A. Overbeek · 1 shared paper, 2022 · strength 0.12
- Marco J. Bruno · 1 shared paper, 2022 · strength 0.12
- Djuna L. Cahen · 1 shared paper, 2022 · strength 0.12
- Derk C.F. Klatte · 1 shared paper, 2022 · strength 0.12
- Gwenny Manel Fuhler · 1 shared paper, 2022 · strength 0.12
- Hans Morreau · 2 shared papers, 2011–2018 · strength 0.09
- Frederik Jan Hes · 2 shared papers, 2011–2018 · strength 0.09
- Nelleke A. Gruis · 2 shared papers, 2011–2018 · strength 0.09
- Wouter H. de Vos tot Nederveen Cappel · 2 shared papers, 2011–2018 · strength 0.09
- Martin N.J.M. Wasser · 2 shared papers, 2011–2018 · strength 0.09
- Berit Velstra · 2 shared papers, 2013–2015 · strength 0.08
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.